Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management
about
Phage therapy against Enterococcus faecalis in dental root canalsTowards Development of Small Molecule Lipid II Inhibitors as Novel AntibioticsAntibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation.Resistance Mechanisms, Epidemiology, and Approaches to Screening for Vancomycin-Resistant Enterococcus in the Health Care SettingPeptides from American alligator plasma are antimicrobial against multi-drug resistant bacterial pathogens including Acinetobacter baumannii.The Two-Component System ChtRS Contributes to Chlorhexidine Tolerance in Enterococcus faeciumCommunity Acquired Enterococcal Urinary Tract Infections and Antibiotic Resistance Profile in North IndiaEpidemiology of antimicrobial resistance in bloodstream infections.Complete Genome Sequence of Enterococcus hirae R17, a Daptomycin-Resistant Bacterium Isolated from Retail Pork in China.Vancomycin-Resistant Enterococci and Bacterial Community Structure following a Sewage Spill into an Aquatic Environment.Automatic Digital Analysis of Chromogenic Media for Vancomycin-Resistant-Enterococcus Screens Using Copan WASPLabHigh frequency of vancomycin resistant Enterococcus faecalis in children: an alarming concern.Emergence of Vancomycin-resistant Enterococci at a Teaching Hospital, Saudi ArabiaAntimicrobial Resistance Surveillance among Intensive Care Units of a Tertiary Care Hospital in Southern India.Genomic insights into the pathogenicity and environmental adaptability of Enterococcus hirae R17 isolated from pork offered for retail sale.Emerging pharmacologic therapies for primary sclerosing cholangitis.When being alone is enough: noncanonical functions of canonical bacterial quorum-sensing systems.Complete Genome Sequence of Enterococcus faecium Commensal Isolate E1002.First case of vanA-positive Enterococcus mundtii in human urinary tract infection in Iran.Small RNAs in vancomycin-resistant Enterococcus faecium involved in daptomycin response and resistance.Weekly screening supports terminating nosocomial transmissions of vancomycin-resistant enterococci on an oncologic ward - a retrospective analysis.Lactobacillus rhamnosus GG Outcompetes Enterococcus faecium via Mucus-Binding Pili: Evidence for a Novel and Heterospecific Probiotic Mechanism.The effect of antibiotic use on prevalence of nosocomial vancomycin-resistant enterococci- an ecologic study.Enterococci and Their Interactions with the Intestinal Microbiome.Characteristics of and Virulence Factors Associated with Biofilm Formation in Clinical Enterococcus faecalis Isolates in China.Surveillance of Antibiotic Use and Resistance in Intensive Care Units (SARI).Association of Enterococcus spp. with Severe Combat Extremity Injury, Intensive Care, and Polymicrobial Wound Infection.Characterization of biofilm formation by Enterococcus faecalis isolates derived from urinary tract infections in China.Mevalonate 5-diphosphate mediates ATP binding to the mevalonate diphosphate decarboxylase from the bacterial pathogen Enterococcus faecalis.Defeating Antibiotic- and Phage-Resistant Enterococcus faecalis Using a Phage Cocktail in Vitro and in a Clot Model.Characterization of a genomic island harbouring a new vanD allele from Enterococcus faecium N15-508 isolated in Canada.Enterococcus gallinarum meningitis: a case report and literature review.Repurposing auranofin as an intestinal decolonizing agent for vancomycin-resistant enterococci.Prevalence and phenotypic characterization of Enterococcus species isolated from clinical samples of pediatric patients in Jimma University Specialized Hospital, south west Ethiopia.Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany - 10 years of surveillance.Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE).First molecular characterization of related cases of healthcare-associated infections involving multidrug-resistant in AlgeriaEremomycin pyrrolidide: a novel semisynthetic glycopeptide with improved chemotherapeutic propertiesComparative genome analysis reveals key genetic factors associated with probiotic property in Enterococcus faecium strains
P2860
Q28071930-A504E104-CD28-4A70-8B19-561E44DA71C7Q28552923-CEB02767-0DE5-46DE-9026-F5DE07E8C0C5Q30238945-156D4F0A-FD3A-4DF7-BD57-9295AA3B72E3Q30251425-92B5E75B-B1DE-4E59-AB76-A9A62B64DEC6Q36108116-F12F5008-69AC-4637-B600-526B07903CEEQ36292464-502F4E30-D671-4289-AFD8-EE9C942A5ABDQ36671856-9250F47A-40B8-4296-AAF5-879A7A6F9A06Q36913239-9FC95628-BEEE-4912-8BD2-60FF5945565EQ37034315-B1E1DA4D-14E7-4431-B6DB-C0ED4C2F8BB9Q37224121-4C9EB225-D700-40E6-B28D-17B1978C03CFQ37280610-B059F020-DBC5-4170-A231-0CC366F27BFEQ37621052-9E53B120-5F41-4CAB-80B0-035537F419CDQ37640967-1262F2FF-B95D-464E-B94A-1B3303474536Q37734128-F1DB5463-E748-46A7-B1E9-84E87AB120BBQ38629272-A5E6378D-DA23-4288-861A-09491BC1F65FQ38751076-CA8A8786-FAD3-4199-BC1E-C25F01E69CB7Q38803545-8E697977-5534-4F00-BF6B-E417991E3FACQ39107940-9072274B-85C6-4CD0-9EAE-69C5B272A71DQ39802724-85EF015E-492C-41CA-ABB9-22A1A1103DE4Q40046452-EF88F7C1-E159-4796-89F9-79E8598408EDQ40197562-052FB3CE-67C4-424F-B4F8-09637899B72DQ40611551-F6266C64-89DF-4B0C-AA6B-8159174F8BF2Q41107919-2F42487C-78D2-4BEE-B390-CED4B32AE1BFQ46819823-AFDFB01E-7BDE-462E-A13A-222BA665008AQ47095627-75D52D92-7C78-490A-AAA2-8856AD5C7081Q47260571-F413D177-012A-4D08-ABC4-9367B4672889Q47277940-1C11BB9C-95EF-4BC6-9FFE-DF149FF5F4DCQ47392637-BBF1A425-210C-487B-A68A-59F2B1357483Q50061572-573F9E2C-C377-48E1-9D44-AD8B37D45436Q52655242-14B15982-869B-4ACC-AD43-722EE0769E45Q53789771-A2858D2F-0514-4673-9D9D-3DAFF044861FQ54203974-03F2BA6F-E198-4B5E-80E4-F224FF4FA1C6Q55016563-0396A99B-BB2F-4AB5-A760-BBC160098B7AQ55280726-183DD68F-C6EB-463D-8DDA-28EDCC75D45AQ55428490-625CE50F-BC4E-49B7-A3FC-824237511978Q55514398-CE1CDD5D-AD8E-4F47-80CE-D31D7116340EQ57074368-8BAB85A6-11A6-40B2-ACFF-F719AB989CF9Q58754588-D8F6B551-9E27-4265-9DF2-C43FF44499BFQ58765736-B0F11F2C-14E0-47E4-BCCD-27D08A965703
P2860
Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Vancomycin-resistant enterococ ...... ations, and optimal management
@ast
Vancomycin-resistant enterococ ...... ations, and optimal management
@en
Vancomycin-resistant enterococ ...... ations, and optimal management
@nl
type
label
Vancomycin-resistant enterococ ...... ations, and optimal management
@ast
Vancomycin-resistant enterococ ...... ations, and optimal management
@en
Vancomycin-resistant enterococ ...... ations, and optimal management
@nl
prefLabel
Vancomycin-resistant enterococ ...... ations, and optimal management
@ast
Vancomycin-resistant enterococ ...... ations, and optimal management
@en
Vancomycin-resistant enterococ ...... ations, and optimal management
@nl
P2860
P3181
P356
P1476
Vancomycin-resistant enterococ ...... ations, and optimal management
@en
P2093
Christopher W Crank
Tristan O'Driscoll
P2860
P304
P3181
P356
10.2147/IDR.S54125
P407
P577
2015-01-01T00:00:00Z